australian patent issued to creagri® for ultraviolet radiation (uvr) protection by its...
DESCRIPTION
Australian Patent Issued to CreAgri®TRANSCRIPT
-
Australian Patent Issued to CreAgri for
Ultraviolet Radiation (UVR) Protection
by its Hydroxytyrosol-Based
Formulations
HAYWARD, Calif., Aug. 26 /PRNewswire/ -- CreAgri, Inc. announced today that the
company has received a Patent by the Australian Patent Office, Patent Number
2003249719, which covers the protective effects provided by Hydroxytyrosol against
skin damage caused by UV exposure.
The patent claims are very broad and include formulations containing the two most
important olive polyphenols, Hydroxytyrosol and Oleuropein, whether delivered orally
and/or in conjunction with topical applications.
"We believe that products containing Hydroxytyrosol, whether orally ingested and/or
topically applied, will provide an effective protection against the edema and erythema
produced by excessive sun exposure, especially in areas of the world where skin
problems are aggravated by the depletion of the ozone layer like Australia," declares Dr.
Roberto Crea, CreAgri's President and CEO and author of the patent. "Increased
exposure to UV rays in humans and animals has been linked to many severe diseases,
including melanoma, carcinoma and immune diseases," adds Dr. Crea.
"The scientifically proven activities of Hydroxytyrosol in decreasing levels of TNF-
alpha and in scavenging free radical molecules may partially explain the protective
effect on skin," adds Dr. Cathy Bitler, CreAgri CSO and first author of a peer-reviewed
publication that describes the anti-inflammatory properties of HT.
Together with its immune-balancing activity, Hydroxytyrosol, provided in high
concentration by CreAgri's proprietary formulation, Hidrox, directly blocks the effects
of UV-induced free radicals in skin and other tissues of the body, and thereby,
decreasing the concomitant inflammation.
Hidrox provides the highest amount of Hydroxytyrosol in its natural environment, as
in the juice of olives. Hidrox is the only Hydroxytyrosolrich formulation in the world produced from organic olives that does not involve extraction by solvents or other
chemical separations.
The product is certified Generally Recognized as Safe (GRAS) and has been
successfully tested in several human trials in many countries of the world, including
USA, Japan and Malaysia.
-
About CreAgri (www.creagri.com)
CreAgri is the world's leading developer and supplier of antioxidant olive polyphenols
for functional foods and beverages, dietary supplements, cosmetics and skincare
applications. For ten years, CreAgri has been the research leader in providing
consumers and industry with the highest quality free radical-scavenging olive
polyphenols. CreAgri's' internationally acclaimed product, HIDROX, has been
formulated for dietary supplements, cosmetics, and skin-care products; all featuring the
antioxidant power of natural HYDROXYTYROSOL, the olive active bio-phenol with
the highest free-radical scavenging activity of any known natural or synthetic
antioxidants.
About HIDROX
HIDROX is CreAgri's trademarked hydroxytyrosol formulation, a powerful
polyphenol scientifically recognized for its anti-oxidant properties and efficacy in heart
and joint health. HIDROX is the only olive polyphenols formulation with GRAS
certification, meaning that it has been subjected to the most comprehensive set of safety
and clinical efficacy tests. HIDROX is also covered by the largest number of
international patents for applications that include hydroxytyrosol and olive polyphenols.
It is available in three forms to fulfill a variety of applications: HIDROX 12% Total
Polyphenols (6% hydroxytyrosol) freeze dried powder, HIDROX 6% Total
Polyphenols (3% hydroxytyrosol) powder and HIDROX0.5% Total Polyphenols
liquid. All products are available in volumes ranging from kilograms to metric tons and
can be ordered directly from CreAgri.
About Skin Cancer
Each year more than 1,200 Australians die from skin cancer and in the US, more than 1
million new cases of skin cancer are diagnosed each year. (1) The American Cancer
Society estimates that there are currently 480,000 cases of melanoma in the US alone
today and that there are 7,700 deaths per year from the disease. Melanoma incidence
rates in Australia and New Zealand are around four times as high as those found in
Canada, the US and the UK. (2) Overall, melanoma is the fourth most common cancer
in Australia. (3)
For more information about CreAgri, visit www.creagri.com. For media related
inquiries, contact Paolo Pontoniere (510) 732-6478 ext. 107, [email protected]
or Gillian Christie at Christie Communications,www.christiecomm.com (805) 969-3744
(1) theozonehole.com, American Cancer Society's 2007 Facts & Figures
(2) Australian Institute of Health and Welfare and Australasian Association of Cancer
Registries. Cancer in Australia 2001. 2004.
-
(3) Australian Institute of Health and Welfare (AIHW) & Australasian Association of
Cancer Registries (AACR). Cancer in Australia: an overview, 2006. Cancer Series
Number 37. Canberra: AIHW, 2007.
SOURCE CreAgri, Inc.